04:26 PM EDT, 09/30/2025 (MT Newswires) -- Jack A. Khattar, Director, President, CEO, on September 29, 2025, sold 10,235 shares in Supernus Pharmaceuticals ( SUPN ) for $491,485. Following the Form 4 filing with the SEC, Khattar has control over a total of 2,149,936 common shares of the company, with 1,144,336 shares held directly and 1,005,600 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1356576/000153993725000022/xslF345X05/wk-form4_1759263862.xml